Preliminary results of clinical use of colchicine in COVID-19 treatment

We report a case of the use of colchicine in a patient infected with SARS-CoV-2 virus. A 37-year-old man with COVID-19 presented with moderate symptoms, mild pulmonary impairment and elevated inflammatory markers, suggesting an increased risk of cytokine storm and possible worsening of clinical cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Knack, Rafael Silvestre, Losso, Luis Carlos, Knack, Renata Silvestre, Hanada, Talie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323388/
https://www.ncbi.nlm.nih.gov/pubmed/34326122
http://dx.doi.org/10.1136/bcr-2021-244482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323388/
https://www.ncbi.nlm.nih.gov/pubmed/34326122
http://dx.doi.org/10.1136/bcr-2021-244482

Ejemplares similares